[Lithium carbonate (Contemnol--Spofa). A clinical study].

Area of Science:

• Pharmacology
• Psychiatry
• Clinical Therapeutics

Context:

• Lithium salts are a cornerstone in managing mood disorders.
• Understanding lithium's pharmacodynamics is crucial for optimizing patient outcomes.
• Current therapeutic strategies require evaluation for efficacy and safety.

Purpose:

• To assess the efficacy and safety of lithium carbonate (Contemnol--Spofa) in inpatients.
• To analyze the mechanisms of action, pharmacodynamics, and therapeutic management of lithium.
• To evaluate indications, contraindications, and side effects in a clinical setting.

Summary:

• A simple-blind study involving 15 inpatients evaluated lithium carbonate.
• Methodology included patient examinations, blood lithium screening, psychological assessments, and laboratory tests.
• Results confirmed efficacy in bipolar disorders, depressions, and related psychosyndromes, with good tolerance and low side effect incidence.

Impact:

• Lithium carbonate demonstrates significant therapeutic and prophylactic value in specific psychiatric conditions.
• Careful patient selection, monitoring, and adherence to guidelines ensure safe and effective lithium therapy.
• This study reinforces the importance of blood lithium screening and clinical surveillance for optimal treatment.